US medical devices industry saw a rise of 35% in overall cross border deal activity during March 2022, when compared with the last 12-month average, led by Fresenius Kabi’s $240m acquisition of Ivenix, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
A total of 27 cross border deals worth $821.5m were announced in March 2022, compared with the 12-month average of 20 deals.
venture financing was the leading category in the month in terms of volume with 21 deals, which accounted for 77.8% of all cross border deals.
In second place was M&A with four cross border deals, followed by private equity with two transactions, respectively accounting for 14.8% and 7.4% of overall deal activity in the US technology industry during the month.
In terms of value of cross border deals, venture financing was the leading deal category in the US medical devices industry with total deals worth $563.5m, while M&A and private equity deals totalled $240m and $18m respectively.
US medical devices industry cross border deals in March 2022: Top deals
The top five medical devices industry cross border deals accounted for 75.2% of the overall value during March 2022.
The combined value of the top five medical devices cross border deals stood at $618m, against the overall value of $821.5m recorded for the month.
The top five medical devices industry cross border deals of March 2022 tracked by GlobalData were:
1) Fresenius Kabi $240m acquisition deal with Ivenix
2) The $125m venture financing of BillionToOne by Adams Street Partners,Baillie Gifford,Civilization Ventures,Fifty Years Fund,Hummingbird Ventures,Libertus Capital,NeoTribe Ventures,Norwest Venture Partners,Pacific 8 Ventures and Time BioVentures
3) Artiman Ventures,Blue Water Life Science Advisors,Cedars-Sinai Medical Center,Healthcare of Ontario Pension Plan,John Doerr,ND Capital,Nissim Capital,Ping An Voyager Partners and Pitango Venture Capital $100m venture financing deal with Visby Medical
4) The $80m venture financing of RefleXion Medical by Ally Bridge Group,Ascension Health Ventures,Catalio Capital Management,Hillenbrand Capital,Johnson & Johnson Innovation – JJDC,KCK Group,Pfizer Venture Investments,PSP INVESTMENTS,Sixty Degree Capital,T Rowe Price Associates,The Rise Fund and Venrock Healthcare Capital Partners
5) Andreessen Horowitz,Bow Capital,Bridger Healthcare Partners,Casdin Capital,Horizons Ventures,Jeff Dean,Koch Disruptive Technologies and Matthew McIlwain $73m venture financing deal with Deepcell
Verdict deals analysis methodology
This analysis considers only announced and completed cross border deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.